Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Nutrition in Clinical Practice
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miles, J. M.
Right arrow Articles by Harris, W. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Miles, J. M.
Right arrow Articles by Harris, W. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Invited Review: Lipoprotein Lipase and Triglyceride-Rich Lipoprotein Metabolism

John M. Miles, MD

Yongsoon Park, PhD

William S. Harris, PhD

Division Of Endocrinology and Metabolism, University of Missouri, Kansas City and Lipid and Diabetes Research Laboratorv. St. Luke's Hospital. Kansas Citv

Lipoprotein lipase (LPL) is the key enzyme responsible for fat storage. It hydrolyzes triglyceride contained in circulating very low-density lipoproteins and chylomicrons; the fatty acids that are produced are transported locally into tissues, whereas glycerol is released into the circulation. Abnormalities in LPL activity have been described in a variety of hypertriglyceridemic states, including diabetes mellitus, and in some situations may contribute to atherosclerosis. Previous in vivo studies suggest that LPL is saturable, with maximum rates of fatty acid transport and storage occurring at plasma triglyceride concentrations in the 300 to 400 mg/dL range. At higher triglyceride concentrations, significant nonenzymatic uptake, primarily by the reticuloendothelial system, can occur. Impaired neutrophil, platelet, and pulmonary function have been described in association with IV infusion of lipid emulsions at high rates. There is no evidence that lipid emulsions produce any of these adverse effects at plasma triglyceride concentrations below 300 to 400 mg/dL. Inordinate hypertriglyceridemia can usually be avoided by limiting lipid infusion rates to 30 to 50 mg/kg-h, a rate sufficient to meet nutritional needs under most conditions.

Nutrition in Clinical Practice, Vol. 16, No. 5, 273-279 (2001)
DOI: 10.1177/088453360101600502


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?